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ABSTRACT: 
Yolk-shell particles (YSPs) have attracted increasing attention from various research fields 
because of their low density, large surface area and excellent loading capacity. However, the 
fabrication of polymer-based porous yolk-shell particles remains a great challenge. In this work, 
multi-functional polycaprolactone (PCL) yolk-shell particles were produced using tri-needle co-
axial electrospraying with a simple nonsolvent process. TiO2-Ag nanoparticles and Ganoderma 
lucidum polysaccharides (GLP) were encapsulated into the outer shell of the YSPs as the major 
antibacterial and antioxidant component, while iron oxide (Fe3O4) nanoparticles were 
incorporated into the inner core to act as a photothermal agent. The morphology and structure, 
chemical composition, biocompatibility, antioxidant and antibacterial effects of the fabricated 
YSPs, photothermal effects and the release profile of the encapsulated GLP were studied in vitro. 
Furthermore, the in vivo wound healing effects of the YSPs and laser-assisted therapy were 
explored based on a burn wound model on c57 mice. 
1. INTRODUCTION 
In the past decade, micro- and nanoparticles with various structures and functions have 
attracted widespread attention in biomedical fields1-2, including but not limited to serving as drug 
release matrices for oral capsules or injectable agents3, being micro-scaffold for 3D cell culture4 
and acting as the platform for multimodal imaging and therapy5. The functionalities of the 
particles largely depend on their surface morphology and internal structure6-8. Micro- and 
nanoparticles with various or unique morphologies (e.g. Janus8, multilayered9, hollow10, 
porous10, mushroom-shape11, single-hole12 and yolk-shell13) have gained specific interest due to 
these morphologies allowing for further development of new and complex functions of the 
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resulting particles10, 14. For instance, pores of such particles accelerate drug release rate15 and 
provide a large area for cells to attach and proliferate16; the void space of hollow particles 
provide opportunities for macromolecule encapsulation17. 
YSPs have caught much attention in recent years due to their intrinsic configuration consisting 
of a movable core with an encircled porous shell; allowing them to possess outstanding 
advantages, including low density, large specific area and excellent loading capacity.18 As a 
result of these, they have become attractive candidates for a great number of biomedical 
applications including biosensing19, drug delivery and theranostics20. 
Methods of synthesizing YSPs are generally divided into four categories: hard-templating 
synthesis, soft-templating synthesis, self-templating synthesis and multimethod combination 
synthesis20. Most of these methods are multistep processes and require additional reaction 
conditions such as injection of inert gas21 or maintaining reaction temperatures22. These factors 
can make it extremely difficult to successfully fabricate YSPs. Current research shows the 
fabrication of YSPs is dependent on the use of metal particles23, non-metal particles24 or 
oxides25-26. However, the utilization of these has proven to show in vivo toxicity27. As a result, 
only polymeric materials are considered for particle engineering for appropriate biosafety, 
biocompatibility and biodegradation28. The use of polymeric materials in YSP fabrication has not 
yet been exploited in publications.  
Tri-needle co-axial electrospraying is a facile and versatile method to produce multilayered 
(more specifically tri-layered) polymeric particles in one-step at ambient temperature29. This 
engineering method allows particles to be collected with a solvent; proving to be a cost-effective 
and convenient way of yielding porous polymeric particles as found in previous studies30.  
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Polycaprolactone (PCL) is a FDA proved biomaterial31, which has been widely used in 
biomedical applications due to its ability to form particles of various structures32.  
TiO2-Ag nanoparticles are metal/semiconductor nanocomposites which are biologically safe, 
exhibit low toxicity and relatively simple to fabricate.33 Due to the presence of silver, these 
nanoparticles have also shown to have promising antibacterial properties33. Combining the 
advantages of both TiO2 and silver can overcome the adverse side effects of silver ions on human 
health34.  
Polysaccharides have been widely reported to successfully aid in wound healing due to their 
biocompatibility, low toxicity and antioxidant activity35. G. lucidum polysaccharides (GLPs) are 
natural bioactives well known for their excellent antioxidant properties and the pharmaceutic 
effects on promoting diabetic wound healing36. 
Iron oxide nanoparticles (Fe3O4) are broadly used in the biomedical remit including imaging, 
drug delivery control, magnetic targeting and photothermal therapy due to its good 
biocompatibility and low toxicity37. 
In this work, polymer-based YSPs were fabricated using tri-needle co-axial electrospraying, 
To evaluate the toxicity and potential biomedical application of the resulting YSPs, PCL was 
selected as the carrier material for the core and the shell with TiO2-Ag nanoparticles and GLP 
being encapsulated within the shell as the major antibacterial and antioxidant component. Fe3O4 
nanoparticles were incorporated into the core to act as a photothermal agent. The morphology, 
structure, chemical composition, biocompatibility, antioxidant and antibacterial properties of the 
fabricated YSPs were studied in vitro alongside the photothermal effects and the release profile 
of the encapsulated GLP. Furthermore, the in vivo wound healing effects of the YSPs and laser-
assisted therapy using the YSPs were tested using a burn wound model on c57 mice. 
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2. MATERIALS AND METHODS  
2.1. Materials and animals. 
PCL (Mw=45000 g/mol) was purchased from Sigma-Aldrich, St Louis. Ethyl cellulose (EC), 
Fe3O4 (nanospheres with diameters of about 20 nm, MNP) and Triton X-100 was purchased from 
Aladdin Chemistry Co., Ltd., Shanghai, China. GLP was purchased from Beijing Jingcheng 
Biotechnology Co., Ltd., Beijing, China. TiO2-Ag NPs (white powder, particle diameter ~30 nm, 
constituting 3 w/w % silver content) were purchased from Hangzhou Wanjing New materials 
Co., Ltd., Hangzhou, China. Ethanol, Phosphate-buffered saline (PBS) and glacial acetic acid 
(HAc) and glycerol were supplied by Sinopharm Chemical Reagent Co., Ltd., Shanghai, China. 
Modified Eagle’s medium (MEM, Gibco) and fetal bovine serum (FBS) were obtained from 
Invitrogen, CA. Cell Counting Kit-8 (CCK-8) was purchased from Dojindo Molecular 
Technologies, Inc. (Kumamoto, Japan). Ultrapure water was produced with a Millipore Milli-Q 
Reference ultrapure water purifier (Molsheim, France).  
Reactive oxygen species (ROS) assay kit was bought from Nanjing JianCheng Bioengineering 
Institute. Rhodamine-phalloidin was obtained from Shanghai Yeasen Biotechnology Co., Ltd 
(Shanghai, China). DAPI dihydrochloride was a product of Beyotime Biotechnology (Shanghai, 
China). Escherichia coli (E. coli) was obtained from Maojie Microbial Sci. & Tech. Co., Ltd., 
Nanjing, China. Staphylococcus aureus (S. aureus) was purchased from National Center for 
Medical Culture Collections, Beijing, China. Violet Red Bile agar and Baird-Parker agar both 
were acquired from Hope Bio-Technogy Co., Ltd., Qingdao, China. 
Adult male C57 mice (N = 18; 6-8 weeks old; body weight over 16 g) were obtained from 
Shanghai Silaike Experiment Animal Co., Ltd. (Shanghai, China). Animal experiments were 
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conducted in animal room with Specific Pathogen Free (SPF) standards. All animal experiment 
protocols were approved by Institutional Animal Care and Use Committee.  
2.2. Yolk-shell microparticle preparation 
The particles prepared in this work were all fabricated using a tri-needle co-axial 
electrospraying system comprising a nozzle of three concentrically aligned stainless steel 
capillaries, a high voltage (Glassman High Voltage Inc), three precision syringe pumps (KD 
Scientific KDS100) and a ground steel ring (diameter = 5 cm). The three different formations 
were injected into the capillaries via silicone tubing; connecting the syringe to the corresponding 
capillary inlet. The power supply was used to introduce an electrical field between the outlet of 
the nozzle and the ground electrode. A high speed digital camera (Baumer TXG02C, Germany) 
connected with the computer was used to observe the real-time jetting behavior during the co-
axial electrospraying process. The applied voltage was kept at 12.0 kV and the flow rates were 
5.0, 1.5, 0.8 mL/h for outer, intermediate and inner layers in all experiments.  
For all samples, the working fluids for the shell and core layer comprised 20 w/v% PCL 
dissolved in HAc with predetermined quantities of GLP, TiO2-Ag NPs or MNPs. The working 
fluid for the middle layer was 20 w/v% EC dissolved in HAc. Mass ratios of GLP/PCL (shell 
layer), TiO2-Ag NP/PCL(shell layer) and MNP/PCL(core layer) were 10%, 10% and 2.5%, 
respectively. 
 2.3. Characterization 
Scanning electron microscopy (SEM) was used to observe the dimension, surface morphology 
and internal structure of the fabricated particles. For SEM observation, the samples were 
attached on the sample holder (a metallic stud) by double-side adhesive tapes for sputter coating. 
A thin layer of gold under vacuum (Ion Sputter MC1000, Hitachi, Japan) was deposited for 90 s. 
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SEM images were captured using a field emission scanning electron microscope (FE-SEM, FEI 
Quanta 650 FEG; Hillsboro, OR). The diameters of the samples were obtained using 740 
particles from the SEM micrographs and analyzed using imageJ software (National Institute of 
Health).  
An automated surface area analyzer (3H-2000PS2, Beishide Instrument Technology Co. Ltd., 
Beijing, China) was used to measure the specific surface area for the samples which had already 
been dried at 30℃ for 2 h. The pore volumes and pore size distributions were derived from the 
adsorption branches of the isotherms using the multipoint BJH (Barrett, Joyner, Halenda) 
method.  
Fourier transform infrared (FTIR) spectroscopy was used to analyze sample composition. 
Pellets for FTIR were prepared by mixing 2 mg of particles with 200 mg of KBr powder by 
grinding and subsequently compressing the mixture into transparent pellets under the pressure of 
12 MPa. The pellets were then scanned by FTIR (IR Affinity 1, Shimadzu, Japan), and the 
spectra were obtained at a resolution of 4 cm-1 ranging from 4000 to 500 cm-1. Each spectrum 
was obtained using 10 scans.  
X-ray diffraction (XRD) was used to confirm the successful encapsulation of MNPs, GLP and 
TiO2-Ag NPs in samples, and spectra were measured with a diffractometer (X’pert PRO; 
PANalytical, the Netherlands) equipped with a standard Cu Kα radiation source (λ=1.5405 Å) 
and scanned within a 2θ range of 5-90° at a step size of 0.026°. The operating voltage and 
current were 40 kV and 40 mA, respectively. 
Magnetization curve of the samples was acquired using a vibration sample magnetometer 
(VSM Mini-CFM measurement system; Cryogenic Ltd., U.K.) at 300 K under a reciprocating 
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altered magnetic field (-10 000 to 10 000 Oe), and saturation magnetization was obtained from 
hysteresis loops.  
Prussian blue staining was used to confirm the presence of iron in the YSPs. Briefly, 20 mg of 
YSPs were incubated with 2% potassium ferrocyanide in 6% hydrochloric acid for 30 min, and 
then washed with deionized water and centrifuged for three times. The final product was 
observed. 
Thermogravimetric (TGA, TA Q50, USA) analysis was performed for PCL, GLP, and porous 
YSPs. TGA was conducted under nitrogen atmosphere by heating the samples from 35 to 800 °C 
at a heating rate of 10 °C/min. A differential scanning calorimeter (DSC, Q20, TA, USA) was 
used to study the thermal behavior of PCL, GLP, and porous yolk-shell particles. The DSC 
thermograms were obtained during heating from 35 to 800 °C at a rate of 10 °C/min. 
2.4. In vitro Photothermal efficiency measurement 
The photothermal efficiency of DI water, DI water with YSPs (with MNP into the particles), 
and DI water with YSPs (without MNP into the particles) were tested. Firstly, 10 mg of samples 
and 0.5 ml of DI water were put introduced to a 1.5 ml Eppendorf tube and vortexed for 30 s for 
complete and uniform mixing. The Eppendorf tubes were then fixed and exposed to an 808 nm 
laser (Power=3 W). Thermal graphs of the tested liquid were captured by a Fluke TI32 IR 
thermal camera. The temperature was calculated from the thermal graphs. 
 2.5. GLP loading capacity (LC) and encapsulation efficiency(EE) 
LC and EE of GLP were determined according to previously mentioned methods.38 LC of GLP 




Amount of GLP encapsualted in the particles (mg)
Weight of the particles (mg)
× 100%    (1) 
The EE of GLP in the porous yolk-shell particles was determined according to Eq. (2):  
𝐸𝐸 (%) =
Amount of GLP encapsulated in the particles (mg)
Theoretical total amount of GLP (mg)
× 100%  (2) 
2.6. In vitro GLP release 
Drug release tests were conducted both without and with laser irradiation (3 W) in vitro. This 
study involved placing 30 mg of sample powder into a glass vial with 15 mL PBS (pH = 7.4) and 
the vials were incubated at room temperature (25 °C) for 72 h. At each specified time interval, 4 
mL of supernatant was removed from the release medium and was replaced with an equal 
volume of fresh PBS. To determine the concentration of GLP, the collected supernatant was 
analyzed using a UV-2600 spectrophotometer (Shimadzu, Japan) at a wavelength of 221 nm. 
The GLP release profile was subsequently drawn based on the quantity of encapsulated GLP 
over time. For each sample, experiments were performed in triplicate. 
2.7. Cell culture 
The L929 mouse fibroblast cells were cultured in 96-well plates containing MEM with 10 
v/v% heat-inactivated fetal bovine serum (FBS, Gibco, USA) and 1% (v/v) antibiotic-
antimycotic at 37 °C in a humidified atmosphere of 5 % CO2. 
2.7.1. Cell morphology detection 
To clearly show the morphology, cells were incubated for 48 h. After incubation, cell growth 
and morphology were observed by fluorescence imaging. The L929 cells were seeded into 6-well 
plates and then incubated with three various concentrations of GLP-loaded YSPs (0.1, 1 and 5 
mg/mL GLP) for 48 h. After incubation, cell growth and morphology were observed by 
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fluorescence imaging. Briefly, cells were firstly fixed through 4 % paraformaldehyde for 30 min 
and then treated with 0.1 % Triton X-100 for 10 min to achieve permeabilization. Rhodamine-
phalloidin (20 min) and DAPI (5 min) with PBS washing in between were used to stain cell 
cytoskeleton and nuclei, respectively. Finally, cells were visualized using an inverted 
fluorescence microscope (Nikon, Eclipse Ti-S, Japan). 
2.7.2. Cck-8 assay 
Cell viability was assessed by Cell Counting Kit-8 (CCK-8). The L929 cells were seeded into 
96-well plates and then incubated with three different concentrations of GLP-loaded YSPs (0.1, 
1 and 5 mg/mL GLP) for 8 h, 24 h or 48 h. The culture medium was then removed and the cells 
were rinsed three times with PBS. After washing, CCK-8 assays were carried out. In brief, 20 µL 
of CCK-8 and 180 µL of MEM were added into the wells and incubated at 37 °C for 3 h. Finally, 
the absorbance of each well was measured through a microplate reader (Multiskan GO, Thermo 




× 100 %  (3) 
where AS, AC and AB represent the absorbance of sample, control and blank groups, 
respectively. 
2.7.3. Live/dead assay 
The culture medium containing H2O2 was removed and the cells were washed with fresh MEM 
three times. A live/dead kit, which contains Calcein-AM and propidium iodide (PI) for live and 
dead cells, was used to counterstain the cells. Images were recorded under an inverted 
fluorescence microscope. 
2.7.4. ROS staining 
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The L929 cells were cultured in 6-well plates for 24 h for fluorescent staining, or cultured in 
96-hole plates for CCK-8 kit. The cells were washed with PBS and then incubated with three 
different concentrations of GLP-loaded YSPs (0.1, 1 and 5 mg/mL GLP) for 72 h. After being 
washed with MEM three times, MEM containing 3.2 mM H2O2 was then added to the wells and 
kept for 12 h after removing the solution. Then three different kinds of staining were conducted 
for visualization. The culture medium containing H2O2 was removed and the cells were washed 
with fresh MEM three times, and then incubated with DCFH-DA (2’,7’-
dichlorodihydrofluorescein diacetate) at 37 °C for 1 h. After the last washing step, the treated 
cells were observed under an inverted fluorescence microscope and ImageJ software was used to 
quantitatively analyze fluorescence intensity. 
2.7.5. Cell scratch assay 
The cell scratch assay is a simple and low-cost method to evaluate the migration ability of cells 
in vitro. Briefly, L929 cells were seeded into 24-well plates at an initial density of 2 × 105 
cells/well and incubated at 37 °C for 24 h. With the help of a ruler, a sterile tip of 200 µL pipette 
was then used to make two perpendicular scratches in each well and the intersection was close to 
the center of the well. After three washes with PBS, the cells were incubated with three various 
concentrations of GLP-loaded YSPs (0.1, 1 and 5 mg/mL GLP) as well as serum-free medium. 
The distribution and quantity of cells in the vicinity of the intersection in each well were checked 
under a microscope and photos were taken out at 0, 24, 72 and 120 h, respectively. 
 
2.8. In vitro anti-bacterial test 
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The anti-bacterial properties of GLP-loaded YSPs were firstly examined through an inhibition 
zone test according to the agar diffusion method. E. coli and S. aureus were selected as 
representatives of Gram-negative (G-) and Gram-positive (G+) bacteria, respectively. Briefly, 20 
mL of Violet Red Bile Agar was poured into sterile petri dishes for E. coli plating while the same 
volume of Baird-Parker Agar was poured into other identical dishes for S. aureus plating. In 
addition, thin solid tablets of GLP-loaded YSPs with a diameter of 13 mm were prepared by 
compressing 50 mg of the powder into pellets under a pressure of 12 MPa. After the plates have 
solidified, 100 μL fresh E. coli and S. aureus suspension was spread on corresponding plates 
before the tablets were positioned on the center of the plates. Finally, the plates were incubated at 
37 °C for 24 h. The diameter of the zone of each sample was measured by Image J software to 
investigate the anti-bacterial activities of GLP-loaded YSPs. 
Secondly, to test the antibacterial effect of the YSPs in humid environment (liquid-solid 
interface), 200 μL of E. coli and S. aureus suspensions with pre-determined mass ratio of YSPs 
(0, 1, 5, 20, 50 mg/ml) was spread on solidified culture medium which were made as previously 
mentioned. The plates were incubated at 37 °C for 24 h and then taken out for the observation of 
the bacteria density. 
Lastly, to test the antibacterial effect of the YSPs in liquid environment, pre-determined weight 
of YSPs (0, 1, 5, 20, 50 mg/ml) were put into 10 ml of E. coli and S. aureus suspensions in 15 ml 
glass tubes. The tubes were incubated at 37 °C for 24 h and the pictures of the tubes were taken 
for comparing the optical density, which indicated the relative amount of the bacteria in the tube. 
2.9. In vivo burn wound healing on c57 mice 
Firstly, a burn wound model was created on every mouse according to an established model39. 
The mice were anesthetized with Pentobarbital sodium. The hair on their back was shaved and 
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completely removed by depilatory cream then washed by DI water. The circular flat face (10 mm 
diameter) of the top of an electric soldering iron cylindrical bar (heated to 200 ℃), was applied 
for 2 s on the central position of the hair-free skin of the mouse with the weight of the mouse 
lying on the heated cylindrical bar. The wound was almost round and slightly larger than 10 mm 
in diameter and was used as a burn wound model for the in vivo experiments. 
After 48 h, the 18 mice were randomly divided into three groups with 6 mice in each of the 
following groups: control group, YSP group, Laser plus YSP group. For the treatment, 5 mg/ml 
YSP suspensions were made by mixing pre-weighted YSPs into 50% glycerol aqueous solution, 
and the suspension were moderately vortexed to ensure that the YSPs were evenly distributed in 
the mixture. 1 ml of 50% glycerol aqueous solution was applied to each mouse in the control 
group. 1 ml of the YSP suspensions were uniformly applied to the burn region on the back of 
every mouse in YSP group and Laser plus YSP group. Low power laser (100 mW) was applied 
to each mouse in Laser plus YSP group after covering the burn with the YSP suspensions. 
Treatment was given once every two days and the mice were sacrificed and the skin of the 
wound area and the peripheral zone was harvested for the later analysis. 
2.10. Wound closure measurements 
Wound area was measured using the digital photographs of the wounds taken every 10 days 
throughout the study. The area was measured by tracing leading edge of the epithelial layer using 
ImageJ software. 
2.11. Histologic evaluation 
The harvested specimens (wound area and its peripheral zone) were immediately fixed in 10% 
neutral buffered formalin, dehydrated through an alcohol gradient, cleaned, and embedded in 
paraffin blocks. Histological sections (7 μm-thick) were prepared using a rotary microtome 
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(Microm HM340E, Thermo Scientific, Waltham, USA) and stained with hematoxylin and eosin 
(HE). In addition, Masson trichrome staining was carried out according to standard procedures. 
2.12. Statistical analysis 
Data from over three independent experiments are reported, and statistical analysis was carried 
out with data from separate specimens. Results are expressed as means ± standard deviation and 
checked by normality tests. Statistical analysis was performed using Origin software. Student's 
paired t-test was performed for comparison of data of paired samples and ANOVA was used for 
multiple group comparisons. A value of p < 0.05 was considered to be statistically significant. 
The significance level is expressed as * p < 0.05 or **p < 0.01. 
 
3. RESULTS AND DISCUSSION   
3.1. Particles fabrication 
The YSPs were synthesized using a tri-needle co-axial electrospray setup, as shown in Figure 
1a. The mechanism of the tri-needle co-axial electrospray process has been discussed in detail in 
a previous study31. The fabricated tri-layered particles were collected using ethanol as non-
solvent6. The stable jetting mode achieved is shown in Figure 1b, however, the boundary 
between different liquids cannot be seen clearly due to the dark color of the GLP particles. The 
formation of the separated layers can be judged from the morphology and structure of the 
particles through scanning electron micrographs. A schematic illustration of the YSPs highlights 
the dispersion of TiO2-Ag and GLP in the porous shell and the magnetic particles (Fe3O4) 
dispersed in the solid core (Figure 1c). 
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Figure 1. (a) Schematic illustrations of the tri-needle co-axial electrospraying system and 
collection system used in this study. (b) Digital graph of the stable jetting mode (under applied 
voltage of 12 kV, flow rates were 5.0, 1.5, 0.8 mL/h for outer, middle and inner capillary). (c) A 
schematic illustration of the structure of the YSPs. The scattered black particles in the core 
represent Fe3O4 nanoparticles, the scattered white and brown particles in the porous shell 
represent TiO2-Ag and GLP particles, respectively. 
 
3.2. Characterizations 
Figure 2a shows the SEM image of the YSPs; which demonstrate the production of particles of 
uniform size. Figure 2b shows that the yielded YSPs have a uniform size distribution with a 
mean diameter of 16.25 ± 3.64 μm. The size uniformity is critical to mass preparation and stable 
aqueous dispersion of YSPs. Large pores are clearly visible on the surface of the YSPS in Figure 
2c whilst Figure 2d exhibits the cross-section view of an YSP, which clearly highlights the three 
distinct layers of the YSPs (a shell, a solid core and a void space in between).  
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Figure 2. (a) Electron micrograph of YSPs. (b) Size distribution of the YSPs. (c) Electron 
micrograph of one of the YSPs of high magnification. (d) Cross-sectional electron micrograph of 
microsphere embedded in epoxy resin.   
 
The BET method is used to measure and analyze the specific surface area and pore size 
distribution of porous materials. Figure 3a shows a N2 adsorption–desorption isotherm of YSPs, 
revealing that the engineered YSPs follow a typical Type III adsorption–desorption mechanism 
due to the relatively weak interactions between YSPs and N2 (according to the IUPAC 
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classification40). Figure 3b exhibits the pore size distribution curve of YSPs (mainly in a wide 
range from 2.0 to 20.0 nm), which shows a main characteristic peak at around 2.6 nm and a side 
peak at about 3.2 nm. This indicates that mesopores occupy a dominant position in the pore 
volume of YSPs. 
 
Figure 3. N2 adsorption–desorption isotherms (a) and pore size distribution curves (b) of YSPs. 
Figure 4 shows the results of the chemical composition of the YSPs. FTIR spectroscopy is 
performed to study the chemical composition of materials and thus confirms the successful 
preparation of products. Figure 4a displays the FTIR spectra of pure GLP, TiO2-Ag, pure MNPs, 
pure PCL and YSPs in the range from 4000 to 500 cm-1 region. For GLP, multiple characteristic 
peaks appear at 3385, 2916, 1637 and 1418 cm-1, which can be assigned to -OH stretching, C-H 
stretching, asymmetrical COO-1 and symmetrical COO-1 stretching, respectively41. A series of 
peaks for TiO2-Ag at about 540 cm
-1 represent the stretching vibration for Ti-O, Ag-O and Ti-O-
Ti bonds42. For MNPs, a characteristic peak at 583 cm-1 indicates the presence of Fe-O bands43. 
In addition, peaks at 2945, 2875 and 1746 cm-1 belong to PCL are associated with CH2 
asymmetric and symmetric stretching as well as C=O stretching, respectively44. The 
corresponding characteristic peaks of GLP are not quite obvious in the final YSP sample, which 
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may be attributable to the excellent encapsulation of GLP in the YSPs, similar to what has been 
reported previously45. However, all other aforementioned peaks all appear in the YSP sample, 
affirming the effective engineering of YSPs without chemical interactions.
 
Figure 4. FTIR spectra (a), XRD spectra (b), DSC curve (c) and TGA curve (d) of the YSPs.  
 
XRD technique was used for determining the crystalline structure of materials. The XRD 
patterns of pure GLP, TiO2-Ag, pure MNPs, pure PCL and YSPs are shown in Figure 4b. Broad 
peaks are shown in the pattern of GLP, highlighting that it is present in a non-crystalline form46. 
For TiO2-Ag, the pattern shows five distinct peaks at 2θ = 25.6°, 37.9°, 48.0°, 54.1° and 62.9° 
indexed to 101, 004, 200, 105 and 204 planes, respectively; mimicking previously reported 
values for pure TiO2
47. For MNPs, there are five characteristic peaks at 2θ = 30.1°, 35.5°, 43.2°, 
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57.0° and 62.6°, corresponding to 220, 311, 400, 511 and 440 planes, respectively, which are 
compatible with the standard values in JCPDS card No. 19-062948.  Two significant peaks are 
present between 20.0° and 25.0° emphasizing the semi-crystalline features of PCL49. The pattern 
of YSPs is similar to the one of PCL since only two characteristic peaks belonging to PCL are 
clearly observed, and the absence of other peaks is due to the low content of GLP, TiO2-Ag and 
MNPs. 
Figure 4c shows the DSC thermograms of pure PCL, pure GLP and YSPs. For pure PCL, the 
curve exhibits two exothermic peaks at 390.6 ℃ and 640.5 ℃. For GLP, there are two 
characteristic peaks at 298.8 ℃ and 539.2 ℃. Furthermore, the curve of YSPs contains two 
sharp peaks at 461.8 ℃ and 564.4 ℃. 
TGA is a technique used to assess the thermal stability of materials over time using a constant 
heating rate. The TGA results are plotted in Figure 4d, showing the changes in weight loss of 
GLP, PCL and YSPs, respectively. Compared to other two samples, the weight of the GLP 
sample was increasing before 60 ℃ due to the hydrophilic nature of GLP. At 160 ℃, the curve 
starts to decrease significantly, and eventually stops at about 600 ℃ with a 26.3 % residue, 
which reveals one-step degradation behavior. In contrast, the PCL sample began to slightly 
degrade at an earlier temperature, and most of the degradation (~ 79 %) was completed between 
350 and 450 ℃, which is consistent with a previously reported result31. Similar characteristics of 
degradation are seen with the YSPs, since YSPs are mainly composed of PCL. In conclusion, 
YSPs acting as carriers of GLP have a delayed main degradation time relative to the active 
pharmaceutical ingredient, which can help the latter to function more effectively. 
The VSM measurement is used to study the magnetic properties of appropriate materials using 
a vibrating-sample magnetometer. Figure 5a shows the hysteresis loop for MNP-loaded YSPs; 
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exhibiting superparamagnetic behavior at room temperature with a saturation magnetization 
value of 0.058 emu/g.  
Targeted transport of drug-loaded particles could be achieved by applying an external 
magnetic field based on the magnetic properties. Amalorpava et al have also shown that the 
properties can be strengthened effectively by increasing the magnetic content50. Figure 5b shows 
the pictures of the YSPs without MNPs (I) and with MNPs (II) in the core after staining by 
potassium ferrocyanide. The stained sample of inset (b) (blue) indicates the successful 
encapsulation of MNPs in the YSPs.51 
 
Figure 5. (a) Magnetic hysteresis loops of YSPs. (b) YSPs without MNP (I) and with MNP (II) 
stained by potassium ferrocyanide. 
 
3.3. In vitro photothermal effect 
The in vitro photothermal effect of the YSPs was evaluated by comparing the peak 
temperatures of the sample EP tubes at determined time points. Since the silver nanoparticles in 
TiO2-Ag particles also possess photothermal effects
52, the YSP samples without MNPs were also 
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tested to assess the photothermal effects caused by the silver nanoparticles and MNPs. PBS was 
tested without any particulate samples as the control group. Figure 6a and Figure 6b shows the 
thermal graphs and temperature rise curves of the three groups. From the thermal graphs and the 
temperature rise curves, the existing silver nanoparticles only have slight photothermal effect 
(Figure 6a, row 2). While the YSP samples with MNP group have remarkable photothermal 
effect and the final temperature reached 71 °C, which was much higher than the YSP samples 
without MNP group (41.7 °C) and the PBS group (37.5 °C). This test confirmed that the main 
photothermal agent in the YSPs are the MNPs rather than the silver nanoparticles, and that the 
MNP can generate heat by photothermal conversion under laser irradiation. The temperature 
spectra of the thermal graphs of the EP tubes also indicated that the YSPs are difficult to 
uniformly disperse in the PBS, so a more suitable delivery medium should be selected when the 





Figure 6. (a) Thermal graphs of the sample EP tubes of the (1) YSP with MNP and TiO2-Ag 
group, (2) YSP containing TiO2-Ag without MNP group, and (3) PBS group at determined time 
points. (b) Peak temperature rise curves of the sample EP tubes of three groups. 
 
3.4. In vitro drug release 
The encapsulation efficiency and the loading capacity of GLP into YSP was 93.43±0.38% and 
6.85±0.03%, respectively. Figure 7a shows the release profile of the encapsulated GLP in the 
YSPs measured at room temperature (25℃). In the first 30 mins a burst release of GLP can be 
seen with over 50% being released, emphasizing the special structure of the YSPs can ensure 
rapid release of the encapsulated GLP from the porous shell. Here after, GLP reease slows with 
over 70% being released after 4 h. a third stage in the release profile shows GLP release being 
sustained at a relatively low release rate. Figure 7b shows a comparison of the release profile of 
GLP for a duration of 2 hours. During the first 30 mins, the amounts of released GLP were 
almost the same. This may be due to the fast heat exchange between the release medium and the 
surrounding air. Because of the accumulation of the heat generated by the photothermal effect, 
the laser group presented faster GLP release rate. 
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Figure 7. (a) Time-dependent release kinetics of GLP without laser irradiation for 3 days. (b) 
Time-dependent release kinetics of GLP with and without laser irradiation for 2 hours. 
3.5. Biocompatibility test 
Cell morphology was assessed by fluorescence microscopy after cells were counterstained 
with DAPI and Rhodamine-Phalloidin for DNA in blue and F-actin in red, respectively. For 
GLP-loaded YSPs, three specific concentrations (0.1, 1 and 5 mg/mL GLP) were processed in 
this way, and merged images are shown in Figure 8a. In contrast with the control group, all three 
GLP-loaded YSP groups promoted cell growth and cell adhesion; the higher the concentration, 
the more apparent these effects highlighting the lack of toxicity.  
 
Figure 8. (a) Cells incubated with YSPs at varying concentrations in culture medium over 48 h. 
Figures are merged fluorescence micrographs of nuclei stained with DAPI (blue) and 
cytoskeleton stained with Rhodamine-phalloidin (red). (b) Cell viability with predetermined 
quantities of YSPs in culture medium over designated times. 
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Cell viability after material treatment is an important indicator to measure the biocompatibility 
of materials. In this study, the effect of GLP-loaded YSPs with three different concentrations 
(0.1, 1 and 5 mg/mL GLP) on cell viability was evaluated using CCK-8 assay. Three designated 
times (8, 24 and 48 h) were applied and the viability was set to 100 % in the control groups. The 
results in Figure 8b specify that there is no significant difference in cell viability among the three 
groups compared with the control groups during observation, which indicates YSPs have 
negligible toxicity and favorable cytocompatibility. 
 
3.6. In vitro anti-oxidant effect 
The effect of therapy of GLP-loaded YSPs on H2O2-treated L929 cell viability was further 
investigated through an anti-oxidant effect test. DCFH-DA, the most common probe for 
revealing intracellular H2O2 and oxidative stress
53, was used to show ROS levels after treatment 
with three different concentrations of GLP-loaded YSPs (0.1, 1 and 5 mg/mL GLP). Typical 
images are shown in Figure 9a. Compared to normal cells that contain almost no labeling, 
fluorescence intensity was significantly increased in H2O2-treated cells, which exhibited a high 
intracellular ROS level. However, the intensity was reduced considerably following the addition 
of GLP-loaded YSPs. Figure 9d shows fluorescence intensity quantitative analysis results, which 
display the dose-dependent ROS scavenging ability of GLP-loaded YSPs. The above results 
support that GLP-loaded YSPs have anti-oxidant effects and can be used for ROS protection, 
which complement the results of the live/dead assay (Figure 9c). 
Figure 9b shows the cell morphology of the cells pre-treated with YSPs loaded MEM after 
treated by H2O2. From the figure, the area of the cell membrane has clearly diminished. It has 
even reduced to the same size of the nucleus, when the cells were co-cultured without YSPs 
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(H2O2) or only with low concentration of YSPs (0.1 mg/ml). When the cells were co-cultured 
with YSPs with a concentration of 1 mg/ml or 5 mg/ml, the area of the cell membrane only 
changed slightly, indicating that the cells could be protected by the bioactive released from 
YSPs. 
The treatment effect of GLP-loaded YSPs on the viability of H2O2-treated L929 cells was 
examined by the live/dead assay, as shown in Figure 9c. Through fluorescence microscopy, live 
cells appear green due to Calcein-AM staining and dead cells are shown in red caused by PI 
staining. Reactive oxygen species (ROS) can cause cellular responses (such as apoptosis) in 
reaction to oxidative stress, and H2O2 was selected as the representative of ROS to prepare 
oxidatively damaged cells. Compared with the control group, the death rate of the H2O2 group 
increased significantly after being treated by H2O2. Three different concentrations of GLP-loaded 
YSPs (0.1, 1 and 5 mg/mL GLP) were then used to deal with the damaged cells. The uniform 
distribution of red and green fluorescence is seen in the low concentration group of GLP (0.1 
mg/ml), designating GLP improves cell viability. Furthermore, the intensity of green 
fluorescence rose considerably in the intermediate (1 mg/ml) and high (5 mg/ml) concentration 
groups. Therefore, reactivation of cell viability is observed and positive correlation with the 
concentrations was determined. The results verify that GLP-loaded YSPs can provide the 
therapeutic effect for H2O2-damaged cells, suggesting that GLP-loaded YSPs has the potential to 
eliminate ROS damage to the human body. 
Moreover, quantitative analysis of cell viability was carried out using CCK-8 assay to evaluate 
the effect of intracellular ROS levels on it (Figure 9e). After H2O2 treatment, cell viability 
dropped dramatically to 32.7 ± 1.3 % as cells were oxidatively damaged. As mentioned above, 
ROS levels declined dramatically due to the incorporation of GLP-loaded YSPs. In the same 
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period, cell viability rose visibly to 67.2 ± 1.2 % and 80.8 ± 3.0 % in the low and medium 
concentration groups, respectively, while high concentration group was back to 98.3 ± 1.8 %, 
approximately the same level as the figure of the control group. The results disclose that GLP-
loaded YSPs can improve cell viability, and there is a negative correlation between intracellular 
ROS levels and the viability.  
 
Figure 9. Anti-oxidant effect. Cells treated with varying concentrations of YSPs for 72 h and 
H2O2 treated for 12 h, then stained with ROS probe (DCFH-DA) (Figure (a)), DAPI and 
Rhodamine-phalloidin (Figure (b)) and live-dead assay (Figure (c)). (d) is the ROS fluorescent 
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intensity calculated from Figure (a). (e) is the cell viability with varying quantities of YSPs after 
H2O2 treatment.  
3.7. Cell scratch assay 
The in vitro cell scratch assay was performed to simulate the therapy effects of GLP-loaded 
YSPs on wound healing. The results are shown in Figure 10. For the control group and the low 
concentration group (0.1 mg/ml), cell adhesion was relatively weak (the cells in the non-
scratched region only filled less than half of the area, which indicated that part of the cells were 
washed away during the cell culture process), and only very few cells migrated to the cross-
shaped area. For the middle concentration group (1 mg/ml), cell density in the non-scratched 
region was obviously higher than the control group and the low concentration group with cell 
migration starting in 72 h then booming after 120 h (almost filled up the cross-shaped area). For 
the high concentration group (5 mg/ml), cell adhesion in the non-scratched area was much 
stronger than all the other groups, which indicated that the extract of the YSPs could potentially 
improve the adhesion of the cells; mainly caused by the nutrients provided by the dissolved GLP 
in the culture medium. However, the cell density in the scratched area is lower than the middle 
concentration group (1 mg/ml), which may be due to the excessive content of YSPs covering the 
cells and hindering the migration of the cells. By comparing the results of the middle and high 
concentration groups, the YSPs mainly enhanced the proliferation and adhesion of the cells, but 
slightly enhanced the migration of the cells. Since cell proliferation and adhesion is important for 
skin wound healing process, these results demonstrated from one side that the YSPs have the 
potential effect in skin wound healing, but the mass ratio of the components need to be further 
considered to achieve better therapeutic effect. In addition, the micrographs also show that the 
YSPs at proper concentrations can enhance cell proliferation of the L929 cells, but no obvious 
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cell migration activity could be observed, which suggests that the extractum of the YSPs mainly 
influence the proliferation and adhesion of cells but have limited functionality to enhance 
migration (motion) of L929 cell.  
 
Figure 10. Optical micrographs of cell scratch assay. The dash lines were added to show the 
boundary of the cross-shaped scratched region created by the tip of a 200 μl pipette. All the scale 
bars represent 100 μm. The dark spots and big clusters distributed on some micrographs are the 
residual YSPs. 
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3.8. In vitro anti-bacterial effect 
The anti-bacterial properties of GLP-loaded YSPs were examined by means of the agar 
diffusion method over a 24 h period. E. coli and S. aureus were chosen as models for Gram-
negative (G-) and Gram-positive (G+) bacteria, respectively. After 24 h incubation, the inhibition 
zones of the tablets are shown in Figure 11a and 11d. Small inhibition zones (with a zone 
diameter of 14.48±0.39 mm in Figure 11a and 16.30±0.17 mm in Figure 11d) prove that GLP-
loaded YSPs can only slightly restrain bacterial growth and infection on solid surface. Figure 
11b and 11e show that the YSPs had good anti-bacterial effect when the concentration of YSPs 
increased to 50 mg/ml in the bacteria solution especially for S. aureus. 
Figure 11c and 11f show that with the increase of the concentration of the YSPs in bacteria 
solution, the black texture (full of printed letter “E”) behind the glass tubes can be seen more and 
more clearly, which indicated a reduction in bacteria.   
To sum up, the results above demonstrated that the YSPs show stronger anti-bacterial effect in 
liquid condition than in dry state, which indicated that the anti-bacterial process of the YSPs 
must have water involved because the incorporated anti-bacterial component TiO2-Ag particles 
show better anti-bacterial effect in water condition. This result confirmed that the YSPs should 
be used in the form of liquid form particle suspension when served as the anti-bacteria agents in 
wound healing process, which is due to the incorporation of water enhanced the interaction 
between the TiO2-Ag nanoparticles and bacteria. 
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Figure 11. Anti-bacterial effect of the YSPs. Inhibition zone test of the YSPs (a and d), and 
bacteria solution with varying concentration of YSPs coated and cultured on the solid culture 
medium (b and e) and cultured in glass tubes (c and f). (The bacteria are E.coli (for a-c) and 
S.aureus (for d-f)). The unit is mg/ml in figures b, c, e and f. 
3.9. Wound healing. 
For the therapy, the mice with burns were randomly divided into three groups (control group, 
YSP group and the Laser plus YSP group). For the control group, 1 ml of 50% glycerol aqueous 
solution was applied to the burn region of each mouse. For the YSP and Laser plus YSP group 
(the concentration of the YSP suspension is 5 mg/ml), 1 ml of the YSP suspensions was 
uniformly applied to the burn region on the back of every mouse. Low power laser (100 mW) 
was applied to each mouse in the Laser plus YSP group following this. Treatment was given 
every two days and the mice were sacrificed and the skin of the wound area and the peripheral 
zone was harvested for the later analysis.  
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As demonstrated in Figure 12a and 12b, the YSPs suspension can moderately increase the 
body temperature of the mice even at a low concentration. The body temperature on the back of 
the mice increased from about 38 °C to 45 °C through 10 minutes’ of laser irradiation and the 
temperature fluctuates around 45 °C which could potentially avoid the secondary injury caused 
by the laser burns. The trend of the temperature is consistent with the in vitro experiments; a 
plateau occurs after a rapid temperature increase at the first period. 
 
Figure 12. (a) Presentative thermal graphs and (b) temperature rise curve of laser plus YSP 
group. (c) Photo and (d) data of wound closure of the three groups. N.S. means no significant 
difference, *p<0.05 and **p<0.01. 
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As demonstrated in Figures 12c and 12d, YSPs and laser irradiation could effectively enhance 
burn wound healing. The laser assisted YSP group achieved 68.97% wound closure was after 10 
days and 84.84% wound closure after 20 days. After 20 days, the laser assisted YSP group 
showed significant difference compared to the other two groups; indicating enhanced wound 
closure when coupled with laser irradiation. Independent application leads to minimal 
enhancement towards wound healing.  
Histomorphological determination on wound regeneration under different treatment was 
conducted by H&E staining and Masson trichrome staining (Figure 13a). Wound regeneration 
was assessed by observing the re-epithelization, fibroblast immigration, connective tissue 
synthesis, and collagen production. The wounds treated with the Laser plus YSP almost 
epithelized in the wound region and the new epidermis was more continuous and uniform than 
the other groups (Figure 13a). 
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Figure 13. (a) H&E staining (a-f) and Masson trichrome staining (g-l) and of three groups on 
day 20. (d-f) and (j-l) are the enlarged micrographs of (a-c) and (g-i), respectively. (b) Pathology 
score. (n=6, day 20). N.S. means no significant difference. 
A  modified scoring system was used based on a scoring system introduced by Babaeijandaghi 
et al54 to quantify pathologic findings of H&E stained and Masson trichrome stained samples. 
Briefly, totally seven criteria were scored for epidermis and dermis, respectively (Table 1). For 
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each criterion, the scoring system was based in order of improving signs from zero to three, that 
is, the higher score represents better finding for wound repair. The sum of these seven scores was 
recorded for each group. In summary, the Laser plus YSP group had the best total pathologic 
score (Figure 13b). In the aspects of epidermal maturation, collagen amount and extension, the 
laser plus YSP group has the best score. All the samples in the three groups got the same score in 
dermal-epidermal separation (2 points) and PMN amount (3 points) which were not shown in 
Figure 13b. However, scores from three experimental groups show non-significant differences, 
which may be due to the limited samples in each group. Furthermore, mice recover at a quicker 
rate than humans. 
Table 1. Histologic scoring system. 
   Score 
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 Clear layer None Blur Focal Clear 













In summary, polymer-base YSPs loaded with TiO2-Ag particles, GLP and MNP particles were 
successfully synthesized using tri-needle co-axial electrospraying combined with post treatment 
of non-solvent. The morphology and internal structure were demonstrated using SEM images. 
Porous features, magnetic properties, and chemical composition of YSPs were confirmed by 
BET, VSM, FTIR and DSC/TGA, respectively. In vitro laser assisted drug release was also 
demonstrated. The YSPs exhibited clear potential as multifunctional platforms for burn wound 
healing applications. Cell experiments showed good biocompatibility and antioxidant effects of 
the YSPs. Antibacterial tests indicated the YSPs have outstanding antibacterial activity against E. 
coli and S. aureus, especially in liquid condition. In vivo burn wound healing on c57 mice 
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